We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ovoca Bio Plc (OVB) Euro 0.125

Sell:0.75p Buy:0.90p 0 Change: 0.16p (24.06%)
Market closed Prices as at close on 24 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.75p
Buy:0.90p
Change: 0.16p (24.06%)
Market closed Prices as at close on 24 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.75p
Buy:0.90p
Change: 0.16p (24.06%)
Market closed Prices as at close on 24 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ovoca Bio PLC is a clinical-stage biopharmaceutical company focused on women’s health. The Company is developing Orenetide, a novel medicinal treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). It is focused on women’s health and identifying novel candidates in areas of high unmet medical need. The Company’s lead product, Orenetide (BP-101), is a novel synthetic peptide for the treatment of HSDD and is conveniently administered through a nasal spray. The spray delivers the drug to olfactory and trigeminal nerves in the nasal cavity where the drug accumulates in the olfactory bulb and further in the brain. It is also developing a new treatment for women affected by low libido or sex drive. It owns a patent portfolio that provides effective protection of its technology. The Company operates in Ireland, the United Kingdom and Russia.

Contact details

Address:
17 Pembroke Street, Upper
DUBLIN
D02 AT22
Ireland
Telephone:
+353 (01) 6619819
Website:
https://ovocabio.com/

Important dates

Future events
There are no future events available.
Past events
AGM 30 November 2023 30/11/23
Interim results 28 September 2023 28/09/23
Final results 30 June 2023 30/06/23
AGM 30 June 2023 30/06/23

General stock information

EPIC:
OVB
ISIN:
IE00B4XVDC01
Market cap:
£672,901
Shares in issue:
81.56 million
Sector:
Mining
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Kirill Golovanov
    Interim Chairman, Chief Executive Officer, Executive Director
  • Dmitriy Nikitashenko
    Vice President - Finance
  • Reneta Nikolova
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.